Moreover, 5‐Aza‐dC treatment and the BSP assay demonstrated that the WTIP promoter region is hypermethylated in NSCLC (Fig. 1C,D), which accounts for the downregulation of WTIP in NSCLC. Here, WTIP is linked to non-small cell lung carcinoma.